40 likes | 151 Views
Understand the role of surgery, radiation, and chemotherapy for Stage IVa laryngeal and hypopharyngeal cancers. Learn about postoperative radiation therapy, chemotherapy as a radiation sensitizer, and palliative care options. Adverse effects and dosage details included.
E N D
What adjuvant treatment is required? • Stage Iva • combined modality • Surgery + radiation • Chemotx+ radiation for advanced larynx or hypopharynxlesions
Radiotherapy For Stage 3 & 4 • Radiation pre or postop • Indicators for postoperative adjuvant radiation therapy: • Presence of negative prognostic factors such as extracapsular spread of tumor, perineural invasion, vascular invasion, fixation to surrounding structures, and multiple positive nodes • Preoperative radiation or chemoradiation therapy • Given when patients have advanced neck disease that involves the carotid artery or the deep neck musculature, in the hope that the tumor reduces in size and becomes resectable. • 50 to 70 Gy over 5 to 7 weeks • Adverse Effect: • Acute: mucositis, skin erythema • Late: fibrosis, xerostomia, altered taste, risk of osteoradionecrosis
Chemotherapy • No survival advantage for HNSCC compared to surgery and/ or radiation • Role of chemotherapy: • as a radiation sensitizer • Palliation (symptom control) of recurrent or unresectable disease, combined with radiation • Cisplatin, carboplatin, 5-FU
References: • Townsend et.al, “Sabiston Textbook of Surgery”, 18th ed.